Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price was up 8% on Thursday . The stock traded as high as GBX 37.80 ($0.50) and last traded at GBX 35.11 ($0.46). Approximately 138,896 shares were traded during trading, an increase of 143% from the average daily volume of 57,163 shares. The stock had previously closed at GBX 32.50 ($0.43).
Celadon Pharmaceuticals Trading Up 19.4 %
The firm has a market capitalization of £25.69 million, a PE ratio of -352.73 and a beta of -0.12. The company has a debt-to-equity ratio of 148.29, a current ratio of 2.62 and a quick ratio of 6.97. The firm’s fifty day moving average is GBX 56.46 and its two-hundred day moving average is GBX 83.04.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Celadon Pharmaceuticals
- 3 REITs to Buy and Hold for the Long Term
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- Comparing and Trading High PE Ratio Stocks
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- Trading Stocks: RSI and Why it’s Useful
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
